Tumor progression & therapeutic resistance--Second International Conference.
Mucke
Hermann A M
HA
HM Pharma Consultancy, Enenkelstrasse 28/32, A-1160 Wien, Austria. office@hmpharmacon.com
D054377:Chemokine CXCL12; D019743:Chemokines, CXC / Q000502:physiology; D018450:Disease Progression; D019008:Drug Resistance, Neoplasm; D038362:Glycogen Synthase Kinase 3 / Q000502:physiology; D000071679:Glycogen Synthase Kinase 3 beta; D006801:Humans; D051550:I-kappa B Kinase / Q000187:drug effects; D008545:Melanoma / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*
C515255:CXCL12 protein, human; D054377:Chemokine CXCL12; D019743:Chemokines, CXC; D000071679:Glycogen Synthase Kinase 3 beta; D051550:I-kappa B Kinase; D038362:Glycogen Synthase Kinase 3